Skip to main content
This website uses cookies to ensure you get the best experience. By continuing to use this site, you agree to the use of cookies.

Please note: Your browser does not support the features used on Addgene's website. You may not be able to create an account or request plasmids through this website until you upgrade your browser. Learn more

Please note: Your browser does not fully support some of the features used on Addgene's website. If you run into any problems registering, depositing, or ordering please contact us at [email protected]. Learn more

Addgene

pCXLE-dCas9VP192-T2A-EGFP Citations (2)

Originally described in: Conditionally Stabilized dCas9 Activator for Controlling Gene Expression in Human Cell Reprogramming and Differentiation.
Balboa D, Weltner J, Eurola S, Trokovic R, Wartiovaara K, Otonkoski T Stem Cell Reports. 2015 Sep 8;5(3):448-59. doi: 10.1016/j.stemcr.2015.08.001. PubMed Journal

Articles Citing pCXLE-dCas9VP192-T2A-EGFP

Articles
Targeted Reactivation of FMR1 Transcription in Fragile X Syndrome Embryonic Stem Cells. Haenfler JM, Skariah G, Rodriguez CM, Monteiro da Rocha A, Parent JM, Smith GD, Todd PK. Front Mol Neurosci. 2018 Aug 15;11:282. doi: 10.3389/fnmol.2018.00282. eCollection 2018. PubMed
Functional Comparison between VP64-dCas9-VP64 and dCas9-VP192 CRISPR Activators in Human Embryonic Kidney Cells. Javaid N, Pham TLH, Choi S. Int J Mol Sci. 2021 Jan 1;22(1). pii: ijms22010397. doi: 10.3390/ijms22010397. PubMed

If you have published an article using this material, please email us at [email protected] to have your article added to this page.